HISTOPATHOLOGY INDIA.COM

                    Myxoid Tumours of Soft Tissue

 
November 2009

Histopathology-India.net

diagnostichistopathology. blogspot.com

Pathopedia-India.com

Surgical-Pathology.com

Pathology-India.com

Pancreatic Pathology Online

Gall Bladder Pathology Online

Paediatric Pathology Online

Paraganglioma-Online

Endocrine Pathology Online

Eye Pathology Online

Ear Pathology Online

Cardiac Path Online

Lung Tumour-Online

Mesothelioma-Online

Pulmonary Pathology Online

Nutritional Pathology Online

Environmental Pathology Online

Pathology Quiz Online

Dermpath-India

GI Path Online

Soft Tissue Pathology

Case Index

Infectious Disease Online; INDEX: A-D ; INDEX: E-L ; INDEX: M-P INDEX: Q-Z ; FUNGAL DISEASE ; VIRAL DISEASE.

E-book - History of  Medicine with special reference to India

Basic Pathology Blog

Environmental Pathology- Smoking

 

Cigarette smoking and Cardio vascular Disease  

Cigarette smoking and Cancer

Non-Neoplastic Diseases in Smokers

Cigarette Smoking and diseases in Women

Environmental Pathology- Alcoholism (Mechanism of Tissue Injury)

Complication of Chronic Alcoholism

Environmental Pathology- Drug Abuse

Environmental Pathology - Iatrogenic Drug Injury:  

Iatrogenic Drug Injury - Oral contraceptives

Environmental Pathology - Effect of Chemicals

Toxic effect of volatile organic solvents and vapors

Toxic effect of agricultural chemicals

Environmental Pathology - Toxic effect of Metal

Lead Intoxication

Mercury Exposure

Arsenic

Cadmium

Nickel

Iron

Environmental Pathology - Physical Agents  

Environmental Pathology-Thermal Regulatory Dysfunction

Environmental Pathology - Hypothermia

Environmental Pathology - Hyperthermia

Environmental Pathology- Electrical Burns

Environmental Pathology- Altitude Related Illnesses

Environmental Pathology - Physical Injuries

Anatomy and Histology of the Normal Lung and Airways

Examination of pulmonary and pleural biopsies

Useful chromatic and immunostains in pulmonary pathology

Percutaneous Needle and Trucut Biopsy Specimen

Bronchial Biopsy Specimen

Transbronchial Biopsy Specimen

Transbronchial biopsy in lung transplant recipients

Open lung biopsy

Lobectomy and pneumonectomy specimen

Histopathological reporting of pulmonary parenchymal biopsies

Histopathological reporting of pulmonary biopsies in cases of Idiopathic Pulmonary Fibrosis

Closed pleural biopsy  ;Open pleural biopsy 

Anatomical Distribution of Pulmonary Disease

Congenital Cystic Adenomatoid  Malformation

Bronchopulmonary Sequestration

Acute Respiratory Distress Syndrome

Neonatal Respiratory Distress Syndrome

Complications of Neonatal Respiratory Distress Syndrome

Sarcoidosis

Extrinsic Allergic Alveolitis 

Pulmonary Eosinophilic Granuloma

Pathological Diagnosis of Granulomatous Lung Diseases

Infectious Granuloma of the Lung

Non-necrotising Granulomatous Inflammation of  the lung

Histopathological Examination of Pulmonary Granulomatous Inflammation

Idiopathic Pulmonary Fibrosis

Usual Interstitial Pneumonia

Non-specific interstitial  pneumonia 

Desquamative interstitial pneumonia

Respiratory bronchiolitis-interstitial lung disease

Acute interstitial pneumonia

Lymphocytic Interstitial Pneumonia / Follicular Bronchiolitis

Pulmonary Vasculitis

Wegener's Granulomatosis of the Lung

Churg-Strauss Syndrome (allergic granulomatosis)

Microscopic Polyangiitis

Isolated Pulmonary Capillaritis

Necrotizing Sarcoid Granulomatosis

Pulmonary Hemorrhage (Eg. Goodpasture's Syndrome)

Pneumoconiosis

Silicosis

Asbestosis

Coal Pneumoconiosis

Talcosis

Exfoliative Pulmonary Cytology

Squamous Cell Carcinoma

Adenocarcinoma

Bronchioloalveolar Cell Carcinoma

Small Cell Carcinoma

Large Cell Carcinoma

Carcinoid Tumours

Metastatic Tumours

Fine Needle Aspiration Cytology

FNAC - Squamous Cell Carcinoma and Adenocarcinoma

FNAC - Bronchioloalveolar Cell Carcinoma

FNAC - Small Cell Carcinoma

FNAC - Non Small Cell and Large Cell Carcinoma

FNAC - Carcinoid Tumours

Cytological Pitfalls in the Diagnosis of Lung Cancer

Role of cytopathology in the diagnosis benign pulmonary tumours

Role of Immunohistochemistry in the diagnosis of lung tumours

Role of cytopathology in the diagnosis of Opportunisitc Infections

Lymphangio leiomyomatosis

Pulmonary Mesenchymal Tumours

Primary Pulmonary Leiomyosarcoma

1. Leukemia - Atom bomb ; Radiologists ; Radiation for ankylosing spondylitis. 2. Breast - Atom bomb ; Local radiation (diagnostic, therapeutic). 3. Angiosarcoma of Liver - Thorium dioxide. 4. Thyroid - Thymic radiation ; Atom bomb. 5. Lung - Uranium miners.6. Skin - Radiologists (fluroscopy). 7.Osteogenic Sarcoma - Radium dial painters.

High doses of radiation cause cancer.

The evidence  comes both from animal experiments and from studies of the effects of occupational exposure, radiotherapy for non-neoplastic conditions, the diagnostic use of certain radioisotopes, and the atom bomb explosions.

There have been reports that years ago scientists and radiologists tested their equipment by placing their hands in the path of the beam. As a result they developed basal and squamous cell carcinomas of the exposed skin. In addition, early instruments were not properly shielded, and the hazards associated with fluoroscopy were not appreciated.

The radiologists of that era suffered an unusually high incidence of leukemia, a situation that has disappeared with the use of modern shielding and protective equipment.

An unusual occupational exposure to radiation occurred among workers who painted radium-containing material onto watches to create luminous dials. These workers were in the habit of licking their paint brushes, which led to the ingestion of the radioactive element and its subsequent localization in their bones. As a consequence, these workers later experienced a high incidence of cancer of the bone and the paranasal sinuses.

Another example of the result of occupational exposure to a radioactive element is the high rate of lung cancer in uranium miners who inhaled radioactive dusts. Since most of these workers also smoke, it is difficult to distinguish the independent from the synergistic effects of radiation in the induction of their cancers, but the evidence favors a synergistic effect.

At one time, thymic irradiation of infants for an ailment known as "status thymico-lymphaticus"  was popular. The infants showed no perceptible improvement in their overall health, but as adults they did develop cancer of the thyroid.

Another example of iatrogenic cancer resulted in  the widespread use of spinal irradiation as a treatment for ankylosing spondylitis. While a beneficial effect on the course of this disease was claimed, the patients later developed of aplastic anemia and myelogenous leukemia.

Radiation delivered by long-lived radioactive isotopes used for diagnostic purposes was also not without danger.

Thorium dioxide (Thorotrast), a material  ingested by phagocytic cells, was at one time used for radionuclide imaging.  Its persistence in the liver resulted in the development of a number of tumours, particularly angiosarcomas.

The survivors of the atom bomb explosions suffered from a number of cancers.  These people exhibited a more than tenfold increase in the incidence of leukemia, which reached its peak from 5 to 10 years after exposure and subsequently declined to background rates. [ An increased incidence of leukemia was evident in those exposed to doses as low as 50 rads in Hiroshima, but required more than 100 rads in Nagasaki. This difference in sensitivity may reflect the greater neutron component of the radiation in Hiroshima.] Two-thirds were acute leukemia ; the remainder were of the chronic myelogenous variety.  Chronic lymphocytic leukemia, an uncommon disease in Japan, showed no increase in incidence. The risk of multiple myeloma increased fivefold and there was a small increment in the incidence of lymphoma.  The risk of the development of solid tumors, although not as great as that for leukemia, was clearly increased for the breast, lung, thyroid, gastrointestinal tract and urinary tract. The development of malignant tumours, including leukemia, showed a dose-response relationship.

Low-level radiation and cancer : The key question that needs to be answered is whether there is a threshold dose of radiation below which there is no increase in incidence of cancer, or whether any exposure carries a significant risk.

Human epidemiologic studies do not provide data precise enough to permit an accurate estimate of cancer risk from low-level radiation, except to suggest that it lies between 0 and some projected upper limit.

Experiments involving the effects of radiation on cells in culture and in other mammals suggest a dose relation that is less than linear for x- and gamma irradiation.

Such a conclusion implies that the established permissible exposures to radiation (which are based on a linear relation) are highly conservative and may exaggerate the risks.

A discussion of the effects of low-level radiation must include consideration of naturally occurring background radiation - that is, the radiation derived from cosmic and terrestrial radiation and the inhalation and ingestion of natural and man-made radioactive isotopes.

This background radiation is estimated at about 100 millirads per year.

Since exposure to this radiation is universal, it is clearly impossible to determine directly whether this level of exposure contributes to the spontaneous incidence of cancer in man.

Various attempts to estimate cancer incidence from the linear hypothesis have yielded conflicting conclusions.

For example, a linear extension back from the observed cancer incidence and radiation exposure among uranium miners predicts a cancer rate that is four times higher than the rate actually observed in a population of nonsmokers.

Cancer mortality has been recorded in two regions of China that have different levels of background radiation.

In the low-background region, people are exposed to 72 millirads per year, while in the high-background region the exposure is almost three times greater.

Despite this difference, no difference in cancer mortality existed.

Moreover, pilots and cabin crews of commercial airlines, who are exposed to significantly higher doses of background radiation at high altitude, have not manifested any increased cancer incidence.

These and other studies suggest that the contribution of background radiation to the occurrence of human cancer may not be as significant as many believe.

The argument for a risk of radiogenic cancer from low-level radiation ( between 1 to 10 rads ) has been indicated by a number of epidemiologic studies.

It has been reported that children exposed to radioactive fallout from atmospheric testing of nuclear weapons had a higher incidence of leukemia than similar children not so exposed. However, close inspection of the data reveals, this apparent increase is explained not by an increased incidence of leukemia relative to the general population, but rather by an unusually low leukemia rate in the controls.   

Another epidemiologic study of radiation associated with nuclear bomb tests involved military personnel engaged in exercises during and after the detonation of a nuclear device named "Smoky" in Nevada in 1957. 

When the data from atomic bomb survivors are subjected to a linear quadratic analysis, the lifetime risk from 1 rad of whole-body x- or gamma irradiation is 1 excess cancer death per 10,000 persons.

Environmental Pathology - Radiation : click

Whole-Body Irradiation: click 

Localized Radiation Injury Associated with Radiotherapy: click 

Cutaneous lesions after exposure to Radiation: click 

                         

Solid tumor risks after high doses of ionizing radiation.Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13040-5.

There is increasing concern regarding radiation-related second-cancer risks in long-term radiotherapy survivors and a corresponding need to be able to predict cancer risks at high radiation doses. Although cancer risks at moderately low radiation doses are reasonably understood from atomic bomb survivor studies, there is much more uncertainty at the high doses used in radiotherapy. It has generally been assumed that cancer induction decreases rapidly at high doses due to cell killing. However, recent studies of radiation-induced second cancers in the lung and breast, covering a very wide range of doses, contradict this assumption. A likely resolution of this disagreement comes from considering cellular repopulation during and after radiation exposure. Such repopulation tends to counteract cell killing and accounts for the large discrepancies between the current standard model for cancer induction at high doses and recent second-cancer data. We describe and apply a biologically based minimally parameterized model of dose-dependent cancer risks, incorporating carcinogenic effects, cell killing, and, additionally, proliferation/repopulation effects. Including stem-cell repopulation leads to risk estimates consistent with high-dose second-cancer data. A simplified version of the model provides a practical and parameter-free approach to predicting high-dose cancer risks, based only on data for atomic bomb survivors (who were exposed to lower total doses) and the demographic variables of the population of interest. Incorporating repopulation effects provides both a mechanistic understanding of cancer risks at high doses and a practical methodology for predicting cancer risks in organs exposed to high radiation doses, such as during radiotherapy.

Risk of postirradiation induction of cancer of the modern methods of radiotherapy (3D CRT and IMRT) head and neck cancer.Otolaryngol Pol. 2004;58(5):887-93.

Ionizing radiation is a known "universal carcinogen" for a wide variety of tumors in man. Human populations are exposed to radiation coming from natural and industrial environment, and from medical sources. However, these are radiotherapy patients who receive the highest doses. Radiation both mutates and sterilizes cells (lethal effect). The risk of cancer induction from cells that have received very high doses of radiation (therapeutic dose about 2 Gy) is lower then from the cells with low doses, since the majority of them will have been sterilized. The epidemiological studies based on the population of atomic bomb survivors have indicated that the most acceptable model of carcinogenesis is the linear non-threshold model. The evaluation of clinical risk related to a wide range of radiation doses, which range from 0.01 Gy to 2 Gy, is connected with many methodological problems such as: differences in treatment factors (dose range, irradiated volume, anatomical site), unknown epidemiological data (smoking abuse, comorbidity), shortening of the follow-up (short lifespan, migration), evaluation of small groups of patients. The most important difficulty is lack of the sufficient knowledge of genetic background which is probably most significant in carcinogenesis process. The introduction into clinical practice of a new sophisticated method of irradiation such as the three-dimensional conformal radiotherapy (3D CRT) or intensity modulated radiotherapy (IMRT) leads to the increase of low irradiation dose for very large volume of normal tissue. Thus, the evaluation of these new methods in the context of carcinogenesis is a very important objective in the future. Today, we can only introduce the most important questions concerned with the risk of carcinogenesis induction which await answers: what is the risk of induction of cancer due to the implementation of these new methods of treatment, and how important is this risk for clinical practice, especially in the case of combined radiochemotherapy? Despite a large body of experimental and clinical studies, radiation carcinogenesis is not fully understood yet. Additional problems related to the impact of irradiation of low dose on carcinogenesis are not resolved. For example, the bystander effect, the low dose hypersensitivity and the adaptive response could modulate the total response after irradiation, but the impact on the carciongenesis is unknown.

Cancer risks from medical radiation.Health Phys. 2003 Jul;85(1):47-59.

About 15% of the ionizing radiation exposure to the general public comes from artificial sources, and almost all of this exposure is due to medical radiation, largely from diagnostic procedures. Of the approximately 3 mSv annual global per caput effective dose estimated for the year 2000, 2.4 mSv is from natural background and 0.4 mSv from diagnostic medical exams. Diagnostic and therapeutic radiation was used in patients as early as 1896. Since then, continual improvements in diagnostic imaging and radiotherapy as well as the aging of our population have led to greater use of medical radiation. Temporal trends indicate that worldwide population exposure from medical radiation is increasing. In the United States, there has been a steady rise in the use of diagnostic radiologic procedures, especially x rays. Radiotherapy also has increased so that today about 40% of cancer patients receive some treatment with radiation. Epidemiologic data on medically irradiated populations are an important complement to the atomic-bomb survivors' studies. Significant improvement in cancer treatment over the last few decades has resulted in longer survival and a growing number of radiation-related second cancers. Following high-dose radiotherapy for malignant diseases, elevated risks of a variety of radiation-related second cancers have been observed. Risks have been particularly high following treatment for childhood cancer. Radiation treatment for benign disease was relatively common from the 1940's to the 1960's. While these treatments generally were effective, some resulted in enhanced cancer risks. As more was learned about radiation-associated cancer risks and new treatments became available, the use of radiotherapy for benign disease has declined. At moderate doses, such as those used to treat benign diseases, radiation-related cancers occur in or near the radiation field. Cancers of the thyroid, salivary gland, central nervous system, skin, and breast as well as leukemia have been associated with radiotherapy for tinea capitis, enlarged tonsils or thymus gland, other benign conditions of the head and neck, or benign breast diseases. Because doses from diagnostic examinations typically are low, they are difficult to study using epidemiologic methods, unless multiple examinations are performed. An excess risk of breast cancer has been reported among women with tuberculosis who had multiple chest fluoroscopies as well as among scoliosis patients who had frequent diagnostic x rays during late childhood and adolescence. Dental and medical diagnostic x rays performed many years ago, when doses were presumed to be high, also have been linked to increased cancer risks. The carcinogenic effects of diagnostic and therapeutic radionuclides are less well characterized. High risks of liver cancer and leukemia have been demonstrated following thorotrast injections, and patients treated with radium appear to have an elevated risk of bone sarcomas and possibly cancers of the breast, liver, kidney, thyroid, and bladder.

Risk estimates for radiation-induced cancer--the epidemiological evidence.Radiat Environ Biophys. 2000 Mar;39(1):17-24.

The risk of low-dose radiation exposures has--for a variety of reasons--been highly politicised. This has led to a frequently exaggerated perception of the potential health effects, and to lasting public controversies. A balanced view requires a critical reassessment of the epidemiological basis of current assumptions. There is reliable quantitative information available on the increase of cancer rates due to moderate and high doses. This provides a firm basis for the derivation of probabilities of causation, e.g. after high radiation exposures. For small doses or dose rates, the situation is entirely different: potential increases of cancer rates remain hidden below the statistical fluctuations of normal rates, and the molecular mechanisms of cancerogenesis are not sufficiently well known to allow numerical predictions. Risk coefficients for radiation protection must, therefore, be based on the uncertain extrapolation of observations obtained at moderate or high doses. While extrapolation is arbitrary, it is, nevertheless, used and mostly with the conservative assumption of a linear dose dependence with no threshold (LNT model). All risk estimates are based on this hypothesis. They are, thus, virtual guidelines, rather than firm numbers. The observations on the A-bomb survivors are still the major source of information on the health effects of comparatively small radiation doses. A fairly direct inspection of the data shows that the solid cancer mortality data of the A-bomb survivors are equally consistent with linearity in dose and with reduced effectiveness at low doses. In the leukemia data a reduction is strongly indicated. With one notable exception -- leukemia after prenatal exposure--these observations are in line with a multitude of observations in groups of persons exposed for medical reasons. The low-dose effects of densely ionizing radiations--such as alpha-particles from radon decay products or high-energy neutrons--are a separate important issue. For neutrons, there is little epidemiological information. This has facilitated exaggerated claims of high neutron effects with reference to alleged dangers from transports of reactor fuel. However, in spite of limited information, it can be shown that the data from Hiroshima exclude the stated claims. New dosimetric information on neutrons may turn out to be highly informative with regard to an upper limit for the potential effects of neutrons and equally with regard to a reassessment--and a possible reduction--of risk estimates for gamma-rays.

Occupational and environmental radiation and cancer.Cancer Causes Control. 1997 May;8(3):309-22.

Epidemiologic evidence on the relation between occupational and environmental radiation and cancer is reviewed. Studies of pioneering radiation workers, underground miners, and radium dial painters revealed excess cancer deaths and contributed to the setting of radiation protection standards and to theories of carcinogenesis. Occupational exposures today are generally much lower than in the past, thus any associated increases in cancer will be difficult to detect. Pooling investigations of these more recently exposed workers, however, has the potential to validate current estimates of risk used in radiation protection. New information on the effects of chronic radiation exposure also may come from studies in the former Soviet Union of Chernobyl clean-up workers and of workers at the Mayak nuclear facilities. Studies of environmental radiation exposures, other than radon, are largely inconclusive, due mainly to the difficulties in detecting the low risks associated with low dose exposures. Thyroid cancer, however, has been linked to environmental radiation from the Chernobyl accident and from nuclear weapons tests. Low-level radiation released during normal operations at nuclear plants has not been found to increase cancer rates in surrounding populations. Radon, a human carcinogen, is the most ubiquitous exposure to human populations; remediating high residential-radon levels is recommended, recognizing that the exposure can never be removed completely because it occurs naturally.

Custom Search


  Disclaimer  ;  Privacy Policy  ; Advertising Policy  ;  E-mail 

Copyright © 2009 surgical-pathology.com
   All rights reserved